UID:
edoccha_9961069023402883
Umfang:
1 online resource (516 p.)
Ausgabe:
2nd ed.
ISBN:
1-280-10150-4
,
9786610101504
,
0-470-85927-X
,
0-470-86164-9
Serie:
WPA Series Evidence and Experience in Psychiatry ; Volume 2
Inhalt:
This series acknowledges the substantial gap that still exists in psychiatry between research evidence and clinical practice: clinicians are sometimes incompletely aware of research findings, or regard them as biased, not convincing or not relevant to their practice. By using systematic reviews with accompanying commentaries this volume is able to assess the ""evidence"" and ""experiences"" to give a critical and objective account of the relevant issues, while focusing on key topics. This comprehensive book addresses schizophrenia through a systematic review of the available research evidence.
Anmerkung:
Description based upon print version of record.
,
VOLUME 2 Schizophrenia Second Edition; Contents; List of Review Contributors; Preface; CHAPTER 1 DIAGNOSIS OF SCHIZOPHRENIA; Diagnosis of Schizophrenia: A Review; COMMENTARIES; 1.1 The Diagnosis of Schizophrenia: Practice and Concept; 1.2 Should Schizophrenia as a Disease Entity Concept Survive into the Third Millennium?; 1.3 On Defining Schizophrenia; 1.4 Diagnosis and Pathophysiology of Schizophrenia; 1.5 The Significance of Intuition for the Diagnosis of Schizophrenia; 1.6 Heterogeneity vs. Homogeneity in Operationally-diagnosed Schizophrenia
,
1.7 Diagnosis of Schizophrenia: Arguments for a Narrowing of the Concept 1.8 Schizophrenia: A Provisional Diagnostic Convention; 1.9 Diagnosing Schizophrenia: A Personal View; 1.10 Comments on the Diagnosis of the Schizophrenic Syndrome; 1.11 The Schizophrenic Syndrome: A Warning and a Conjecture; 1.12 A Century of Schizophrenia is Enough; 1.13 Diagnosis of Schizophrenia: A View from Developing Countries; 1.14 Studies on Schizophrenic Symptomatology in Peru; 1.15 Neuropsychological and Psychophysiological Contributions to the Diagnosis of Schizophrenia
,
CHAPTER 2 PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA Pharmacological Treatment of Schizophrenia: A Review; COMMENTARIES; 2.1 Pharmacotherapy of Psychotic Disorders: A Perspective on Current Developments; 2.2 Pharmacotherapy of Schizophrenia: Gaps in our Knowledge; 2.3 Atypical Antipsychotic Drugs and Schizophrenia; 2.4 Compliance Issues and the New Antipsychotics; 2.5 Schizophrenia and Second-generation Antipsychotics: Mechanistic Implications and Potential for Early Intervention; 2.6 Dose and Duration of Antipsychotic Treatment: Key Variables, Critical Uncertainties
,
2.7 Dosing Problems of Classical Neuroleptics and the Relevance of Novel/Atypical Antipsychotics in the Pharmacotherapy of Schizophrenic Disorders 2.8 Can We Use Pharmacotherapy More Logically in Schizophrenia and Other Psychoses?; 2.9 Long-term Treatment in Schizophrenia: For Whom and How Long?; 2.10 Novel Antipsychotics in Schizophrenia and Related Disorders: Preliminary Findings from a First-episode Study; 2.11 The Pharmacotherapy of Schizophrenia in Clinical Practice; 2.12 A New Era of Hope in Treating Persons with Schizophrenia; 2.13 New Perspectives in Antipsychotic Pharmacotherapy
,
2.14 Some Aspects of the Maintenance Treatment of Schizophrenia 2.15 Highlights on the Management of Schizophrenia; 2.16 Pharmacotherapy of Schizophrenia: The Case of Developing Countries; CHAPTER 3 PSYCHOTHERAPIES FOR SCHIZOPHRENIA; Psychotherapies for Schizophrenia: A Review; COMMENTARIES; 3.1 Relevant Methods, Goals, Time-dimensions and Emotional Influences in the Psychotherapy of Schizophrenia; 3.2 Family and Individual Cognitive-Behavioural Interventions; 3.3 It is no Longer Surprising that Cognitive-Behavioural Therapy Reduces Distressing Psychotic Symptoms
,
3.4 Serious Questions Remain Concerning Efficacy, Effectiveness and Scope of Family Interventions in Schizophrenia
Weitere Ausg.:
ISBN 0-470-84964-9
Sprache:
Englisch
